{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:07:20Z","timestamp":1792040840682,"version":"4.4.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Dyslipidemia is a critical driver in the development of coronary heart disease (CHD), which further exacerbates the risk of major adverse cardiovascular events (MACEs). Chinese herbal medicine (CHM) plays an important role in the regulation of lipid levels and improvement of prognosis. However, few systematic reviews report whether the efficacy of CHM therapy for regulating lipid levels and lowering cardiovascular events is associated with baseline lipid levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Randomized controlled trials assessing efficacy of CHM for lipid profiles and MACEs among patients with CHD were searched in six databases. Two authors independently extracted studies according to a predesigned form. Cochrane risk of bias tool and Grading of Recommendations Assessment, Development, and Evaluation system were used to assess the methodological quality of the included studies. The primary outcomes were blood lipid levels and MACEs including cardiovascular mortality, non-fatal myocardial infarction, revascularization, angina pectoris, heart failure, and non-fatal stroke across baseline lipid levels. The secondary outcomes were individual components of the primary outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 23 trials with 7,316 participants were included in this study. Altogether 377 cardiovascular events occurred in 3,670 patients in the CHM group, while 717 events occurred in 3,646 patients in the Western medicine\u2013alone group. Compared with the Western medicine alone, additional CHM significantly lowered low-density lipoprotein cholesterol (LDL-C) [MD\u2009=\u2009\u22120.46, 95% CI (\u22120.60 to \u22120.32), <jats:italic>P\u2009<\/jats:italic>&amp;lt;\u20090.00001, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200996%]. The risk reduction in MACEs associated with CHM vs. Western medicine therapy was 0.52 [95% CI (0.47\u20130.58), <jats:italic>P\u2009<\/jats:italic>&amp;lt;\u20090.00001, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup><jats:italic>\u2009<\/jats:italic>=\u20090%], but varied by baseline LDL-C level (<jats:italic>P\u2009<\/jats:italic>=\u20090.03 for interaction). Triglycerides (TG) level was also significantly lowered by additional CHM vs. Western medicine alone [MD\u2009=\u2009\u22120.27, 95% CI (\u22120.34 to \u22120.20), <jats:italic>P\u2009<\/jats:italic>&amp;lt;\u20090.00001, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200981%], and risk reduction for MACEs also varied with baseline TG, with greater risk reduction in higher baseline TG subgroups (<jats:italic>P\u2009<\/jats:italic>=\u20090.03 for interaction). Similar results were observed with total cholesterol and high-density lipoprotein cholesterol.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Compared with Western medicine alone, additional CHM was associated with lower risk of cardiovascular events and improvement of lipid profiles. Risk reduction for cardiovascular events was associated with baseline LDL-C and TG levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO<\/jats:ext-link>, identifier CRD42023425791.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1407536","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T04:45:06Z","timestamp":1720673106000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Traditional Chinese medicine lowering lipid levels and cardiovascular events across baseline lipid levels among coronary heart disease: a meta-analysis of randomized controlled trials"],"prefix":"10.3389","volume":"11","author":[{"given":"Lihua","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanlin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"ezad286","DOI":"10.1093\/ejcts\/ezad286","article-title":"2022 Joint ESC\/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG","volume":"64","author":"Byrne","year":"2023","journal-title":"Eur J Cardiothorac Surg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/s0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/circulationaha.114.012477","article-title":"Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease","volume":"131","author":"Navar-Boggan","year":"2015","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2020.07.019","article-title":"Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting","volume":"159","author":"Soppert","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7326\/m14-2957","article-title":"Effects of proprotein convertase subtilisin\/kexin type 9 antibodies in adults with hypercholesterolemia: a systematic review and meta-analysis","volume":"163","author":"Navarese","year":"2015","journal-title":"Ann Intern Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1161\/circulationaha.119.041998","article-title":"Association between triglyceride lowering and reduction of cardiovascular risk across multiple lipid-lowering therapeutic classes: a systematic review and meta-regression analysis of randomized controlled trials","volume":"140","author":"Marston","year":"2019","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1001\/archinte.166.17.1814","article-title":"The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials","volume":"166","author":"Hulten","year":"2006","journal-title":"Arch Intern Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ahj.2015.11.014","article-title":"Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease","volume":"173","author":"O'Brien","year":"2016","journal-title":"Am Heart J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1093\/eurheartj\/ehy182","article-title":"Adverse effects of statin therapy: perception vs. the evidence\u2014focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract","volume":"39","author":"Mach","year":"2018","journal-title":"Eur Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2545476","DOI":"10.1155\/2022\/2545476","article-title":"Evidence and potential mechanisms of traditional Chinese medicine for the adjuvant treatment of coronary heart disease in patients with diabetes mellitus: a systematic review and meta-analysis with trial sequential analysis","volume":"2022","author":"Wei","year":"2022","journal-title":"J Diabetes Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"113436","DOI":"10.1016\/j.jep.2020.113436","article-title":"Dingxin Recipe IV attenuates atherosclerosis by regulating lipid metabolism through LXR-\u03b1\/SREBP1 pathway and modulating the gut microbiota in ApoE-\/- mice fed with HFD","volume":"266","author":"Zhang","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/acm.2008.0400","article-title":"The efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure in coronary patients","volume":"15","author":"Tam","year":"2009","journal-title":"J Altern Complement Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"Br Med J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1001\/jama.2018.2525","article-title":"Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis","volume":"319","author":"Navarese","year":"2018","journal-title":"JAMA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.bja.2019.08.015","article-title":"Use of the grade approach in systematic reviews and guidelines","volume":"123","author":"Granholm","year":"2019","journal-title":"Br J Anaesth"},{"key":"B18","doi-asserted-by":"publisher","first-page":"115391","DOI":"10.1016\/j.psychres.2023.115391","article-title":"Selection of the optimal dose of sertraline for depression: a dose-response meta-analysis of randomized controlled trials","volume":"327","author":"Luo","year":"2023","journal-title":"Psychiatry Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.16368\/j.issn.1674-8999.2018.09.418","article-title":"Effect of Shexiang Baoxin pill on prognosis of patients with acute coronary syndrome after PCI","volume":"33","author":"Xu","year":"2018","journal-title":"J Chin Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.13422\/j.cnki.syfjx.2016040154","article-title":"Randomized controlled trial of Wenxin decoction for unstable angina","volume":"22","author":"Li","year":"2016","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"B21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3969\/j.issn.1004-745X.2016.02.008","article-title":"Clinical observation on Yixin decoction on the treatment of 200 cases with stable angina pectoris of coronary heart disease","volume":"25","author":"Yang","year":"2016","journal-title":"J Emer Tradl Chin Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3969\/j.issn.1008-8849.2021.07.016","article-title":"Effect of Huazhuo Yixin Yin on serum lipid metabolism disorder and cardiovascular adverse events in patients with phlegm turbidity syndrome after PCI for coronary heart disease","volume":"30","author":"Zhou","year":"2021","journal-title":"Mod J Integ Trad Chin West Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3760\/j.issn.1673-4777.2021.02.005","article-title":"Effect of Tongmai Huayu decoction on clinical symptoms and coronary restenosis in elderly patients with coronary heart disease after percutaneous coronary intervention","volume":"16","author":"Tang","year":"2021","journal-title":"Chin Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3969\/j.issn.1008-8849.2021.02.017","article-title":"Effect of Yiqi Huayu Tongluo therapy on qi deficiency and blood stasis syndrome and cardiovascular adverse events in patients with coronary heart disease after interventional surgery","volume":"30","author":"Qin","year":"2021","journal-title":"Mod J Integ Trad Chin West Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3969\/j.issn.1004-745X.2016.08.042","article-title":"Analysis of curative effect and prognosis of integrated traditional Chinese and western medicine on patients with acute coronary syndrome","volume":"25","author":"Tang","year":"2016","journal-title":"J Emer Trad Chin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.13288\/j.11-2166\/r.2010.07.007","article-title":"Effect of anxin granule on the restenosis after percutaneous coronary intervention","volume":"51","author":"Cheng","year":"2010","journal-title":"J Trad Chin Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3969\/j.issn.1000-7369.2015.11.011","article-title":"Effect and safety analysis of Yiqi Tongmai decoction combined with conventional western medicine in treating patients with angina pectoris after myocardial infarction","volume":"36","author":"Ma","year":"2015","journal-title":"Shaanxi J Trad Chin Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.13862\/j.cnki.cn43-1446\/r.2015.14.024","article-title":"Clinical observation of Shenqi Fumai formula on the treatment of 38 cases of acute myocardial infarction of qi deficiency and blood stasis type","volume":"21","author":"Zhang","year":"2015","journal-title":"Guiding J Trad Chin Med Pharm"},{"key":"B29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3969\/j.issn.1000-7369.2018.02.014","article-title":"Effect of Shenzhu Guanxin recipe on blood lipid intervention in patients with stable angina pectoris and its influence on angina pectoris attack","volume":"39","author":"Li","year":"2018","journal-title":"Shaanxi J Trad Chin Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.13193\/j.archtcm.2008.10.130.chenwl.023","article-title":"Clinical study of the formula with soothing the liver reduce phlegm and absorb clots methods on patients with unstable angina pectoris","volume":"10","author":"Chen","year":"2008","journal-title":"Chin Arch Trad Chin Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.13193\/j.archtcm.2011.03.225.linn.067","article-title":"Clinical observation on variant angina pectoris by the method of traditional Chinese medicine combined with western medicine","volume":"29","author":"Lin","year":"2011","journal-title":"Chin Arch Trad Chin Med"},{"key":"B32","first-page":"134","article-title":"Clinical observation on the treatment of acute coronary syndrome with combination of traditional Chinese medicine and western medicine","volume":"3","author":"Zhao","year":"2004","journal-title":"J Emer Trad Chin Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.19656\/j.cnki.1002-2406.20220314","article-title":"Effect of Yugeng Tongyu decoction on levels of blood lipids, cTnT and BNP in patients with AMI after PCI","volume":"39","author":"Kong","year":"2022","journal-title":"Infor Trad Chin Med"},{"key":"B34","first-page":"194","article-title":"Clinical observation on the treatment of acute coronary syndrome with Shengxian decoction and Xiaoxianxiong decoction","volume":"20","author":"Dai","year":"2011","journal-title":"J Emer Trad Chin Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.12102\/j.issn.1672-1349.2022.20.018","article-title":"Clinical efficacy of Yixin Tongmai recipe in treating patients with qi deficiency and blood stasis syndrome after PCI for coronary heart disease","volume":"20","author":"Tan","year":"2022","journal-title":"Chin J Integ Med Cardio-Cerebrovasc Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.19664\/j.cnki.1002-2392.2011.04.023","article-title":"Wenyang Yixin therapy in the treatment of patients with acute coronary syndrome","volume":"39","author":"Li","year":"2011","journal-title":"Acta Chin Med Pharm"},{"key":"B37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3969\/j.issn.1008-1070.2011.03.013","article-title":"Prospective study of different doses of atorvastatin plus traditional Chinese medicine in the treatment of patients with borderline lesion of coronary heart disease","volume":"46","author":"Sun","year":"2011","journal-title":"Chin J Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.11653\/syfj2013160305","article-title":"Influence of traditional Chinese medicine combined with atorvastatin on prognosis, blood lipid and inflammation in borderline lesion coronary heart disease","volume":"19","author":"Li","year":"2013","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"B39","first-page":"607","article-title":"Effects of Naoxintong capsule on the inflammation and prognosis in borderline lesion coronary heart disease patients","volume":"32","author":"Li","year":"2012","journal-title":"Chin J Integ Trad West Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3760\/cma.j.issn.1008-6706.2009.08.111","article-title":"Clinical observation on the therapeutic effect of Ningxin decoction on coronary heart disease","volume":"16","author":"Zhao","year":"2009","journal-title":"Chin J Prim Med Pharm"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.amjcard.2008.02.056","article-title":"Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction","volume":"101","author":"Lu","year":"2008","journal-title":"Am J Cardiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1001\/jama.2018.20045","article-title":"Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease","volume":"321","author":"Ference","year":"2019","journal-title":"JAMA"},{"key":"B43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1161\/circulationaha.113.003008","article-title":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation","volume":"128","author":"Varbo","year":"2013","journal-title":"Circulation"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/heartjnl-2020-318760","article-title":"Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges","volume":"107","author":"Packard","year":"2021","journal-title":"Heart"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the strength randomized clinical trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"JAMA"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3c","DOI":"10.1016\/j.amjcard.2006.11.016","article-title":"Safety considerations with fibrate therapy","volume":"99","author":"Davidson","year":"2007","journal-title":"Am J Cardiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/nutrit\/nux047","article-title":"Lipid-lowering nutraceuticals in clinical practice: position paper from an international lipid expert panel","volume":"75","author":"Cicero","year":"2017","journal-title":"Nutr Rev"},{"key":"B51","doi-asserted-by":"publisher","first-page":"109375","DOI":"10.1016\/j.biopha.2019.109375","article-title":"The role of traditional Chinese medicine in the treatment of atherosclerosis through the regulation of macrophage activity","volume":"118","author":"Jian","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"B52","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.atherosclerosis.2018.08.039","article-title":"Treatment of atherosclerosis by traditional Chinese medicine: questions and quandaries","volume":"277","author":"Wang","year":"2018","journal-title":"Atherosclerosis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.19540\/j.cnki.cjcmm.20230306.703","article-title":"Intervention effect of Chuanxiong-Chishao herb pair on circRNA\/lncRNA expression profile in a myocardial infarction-atherosclerosis model","volume":"48","author":"Yuan","year":"2023","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B54","doi-asserted-by":"publisher","first-page":"107501","DOI":"10.1155\/2014\/107501","article-title":"Protective effect of tetramethylpyrazine on myocardial ischemia-reperfusion injury","volume":"2014","author":"Qian","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"115501","DOI":"10.1016\/j.biopha.2023.115501","article-title":"Salvia miltiorrhiza and Tanshinone IIA reduce endothelial inflammation and atherosclerotic plaque formation through inhibiting COX-2","volume":"167","author":"Ma","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B56","first-page":"2038","article-title":"Traditional Chinese medicine for lipid metabolism disorders","volume":"9","author":"Li","year":"2017","journal-title":"Am J Transl Res"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1407536\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T04:45:48Z","timestamp":1720673148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1407536\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":56,"alternative-id":["10.3389\/fcvm.2024.1407536"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1407536","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,11]]},"article-number":"1407536"}}